AMGN compared with CRBU: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

CRBUCaribou Biosciences, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

CRBUCaribou Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

CRBU2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±30.9%▲+8.83%×0.28

Q2 FY26±44.6%▼−1.86%×0.04

= impliedAMGN realized, solidCRBU realized, hatchedOne scale, both sides: full bar = 45%× = |realized| ÷ impliedspan: AMGN 273d · CRBU 84dSource: market data

AMGNAmgen Inc

465.26▲+1.05%· post 465.00

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

CRBUCaribou Biosciences, Inc.

0.42▼−7.11%· post 0.42

ClosedNov 9 '26

Mkt cap$45.4MRevenue$2MQ3 FY26Revenue$11MFY25

Compare

ClosedNov 9 '26

AMGNAmgen Inc

CRBUCaribou Biosciences, Inc.

465.26▲+1.05%post 465.00

Price

0.42▼−7.11%post 0.42

$249.0B

Mkt cap

$45.4M

Q3 FY26$10.4B

Revenue

$2MQ3 FY26

FY25$36.8B

Revenue

$11MFY25

AMGN465.26▲+1.05%vsCRBU0.42▼−7.11%ClosedNov 9 '26